CLINICAL TRIALS PROFILE FOR ANTIHEMOPHILIC FACTOR (RECOMBINANT)
✉ Email this page to a colleague
All Clinical Trials for antihemophilic factor (recombinant)
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00157040 ↗ | Study of Pharmacokinetics, Efficacy, and Safety of a Recombinant and Protein-Free Factor VIII (rAHF-PFM) in Pediatric Patients With Hemophilia A | Completed | Baxalta now part of Shire | Phase 2/Phase 3 | 2002-06-07 | The purpose of this study is to evaluate whether rAHF-PFM is effective and safe in the treatment of children with hemophilia A. The study consists of 2 parts. Part 1 of the study is a pharmacokinetic evaluation, and Part 2 is an evaluation of efficacy and safety. |
| NCT00157040 ↗ | Study of Pharmacokinetics, Efficacy, and Safety of a Recombinant and Protein-Free Factor VIII (rAHF-PFM) in Pediatric Patients With Hemophilia A | Completed | Baxalta US Inc. | Phase 2/Phase 3 | 2002-06-07 | The purpose of this study is to evaluate whether rAHF-PFM is effective and safe in the treatment of children with hemophilia A. The study consists of 2 parts. Part 1 of the study is a pharmacokinetic evaluation, and Part 2 is an evaluation of efficacy and safety. |
| NCT00157105 ↗ | Safety and Efficacy Study of a Recombinant and Protein-Free Factor VIII (rAHF-PFM) in Hemophilia A Patients Undergoing Surgery | Completed | Baxalta now part of Shire | Phase 2/Phase 3 | 2001-02-12 | The purpose of this study is to evaluate whether rAHF-PFM is safe and effective in the treatment of hemophilia A patients undergoing surgery. |
| NCT00157105 ↗ | Safety and Efficacy Study of a Recombinant and Protein-Free Factor VIII (rAHF-PFM) in Hemophilia A Patients Undergoing Surgery | Completed | Baxalta US Inc. | Phase 2/Phase 3 | 2001-02-12 | The purpose of this study is to evaluate whether rAHF-PFM is safe and effective in the treatment of hemophilia A patients undergoing surgery. |
| NCT00168090 ↗ | Study of Safety and Efficacy of Antihemophilic Factor/Von Willebrand Factor Complex in Surgical Subjects With Von Willebrand Disease (vWD) | Completed | CSL Behring | Phase 4 | 2001-10-01 | The purpose of this study is to test the safety and effectiveness of Humate-P® to prevent bleeding in patients with von Willebrand Disease who are undergoing surgery. |
| NCT00189982 ↗ | Efficacy and Safety Study of a Recombinant and Protein-Free Factor VIII (rAHF-PFM) in Pediatric Patients in Canada With Hemophilia A - A Continuation of Baxter Study 060101 | Completed | Baxalta now part of Shire | Phase 2/Phase 3 | 2004-12-17 | The purpose of this study is to evaluate whether rAHF-PFM is safe and effective in the treatment of children with hemophilia A. The study is open to pediatric patients in Canada who completed Baxter Study 060101. |
| NCT00189982 ↗ | Efficacy and Safety Study of a Recombinant and Protein-Free Factor VIII (rAHF-PFM) in Pediatric Patients in Canada With Hemophilia A - A Continuation of Baxter Study 060101 | Completed | Baxalta US Inc. | Phase 2/Phase 3 | 2004-12-17 | The purpose of this study is to evaluate whether rAHF-PFM is safe and effective in the treatment of children with hemophilia A. The study is open to pediatric patients in Canada who completed Baxter Study 060101. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for antihemophilic factor (recombinant)
Condition Name
Clinical Trial Locations for antihemophilic factor (recombinant)
Trials by Country
Clinical Trial Progress for antihemophilic factor (recombinant)
Clinical Trial Phase
Clinical Trial Sponsors for antihemophilic factor (recombinant)
Sponsor Name
